Skip to menu Skip to content Skip to footer

2009

Journal Article

The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients

Johnson, D. W, Clark, C, Isbel, N, Hawley, C, Beller, E, Cass, A, de Zoysa, J, McTaggart, S, Playford, G, Rosser, B, Thompson, C and Snelling, P (2009). The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Peritoneal Dialysis International, 29 (3), 303-309. doi: 10.1177/089686080902900315

The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients

2009

Journal Article

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

Barraclough, K.A., Staatz, C.E., Isbel, N.M. and Johnson, D.W. (2009). Therapeutic monitoring of mycophenolate in transplantation: Is it justified?. Current Drug Metabolism, 10 (2), 179-187. doi: 10.2174/138920009787522205

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

2009

Conference Publication

Oxidative stress markers in alternate nightly noctural haemodialysis

Van Eps, CL, Coombes, JS, Matsumoto, A, Jeffries, JK, Johnson, DW, Campbell, SB, Isbel, NM, Mudge, DW and Hawley, CM (2009). Oxidative stress markers in alternate nightly noctural haemodialysis. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrolog, Hobart, Tasmania, Australia, 7–9 September 2009. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2009.001176.x

Oxidative stress markers in alternate nightly noctural haemodialysis

2009

Conference Publication

NO IMPROVEMENT IN CARDIAC STRUCTURE AND FUNCTION IN ALTERNATE NIGHTLY HAEMODIALYSIS

Van Eps, CL, Jeffries, L, Haluska, B, Hawley, CM, Jeffries, J, Johnson, DW, Campbell, SB, Isbel, NM, Mudge, DW and Marwick, TH (2009). NO IMPROVEMENT IN CARDIAC STRUCTURE AND FUNCTION IN ALTERNATE NIGHTLY HAEMODIALYSIS. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7–9 September 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

NO IMPROVEMENT IN CARDIAC STRUCTURE AND FUNCTION IN ALTERNATE NIGHTLY HAEMODIALYSIS

2009

Conference Publication

The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events

Kaisar, M, Armstrong, K, Hawley, C, Pidcock, R, Johnson, D, Prins, JB, Marwick, T and Isbel, N (2009). The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7 - 9 September, 2009. Carlton, Australia: Wiley Interscience.

The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events

2009

Conference Publication

Body mass index is independently associated with inflammatory burden in patients with chronic kidney disease

Petchey, WG, Campbell, S, Van Eps, C, Mudge, D, Johnson, D, Hawley, C and Isbel, N (2009). Body mass index is independently associated with inflammatory burden in patients with chronic kidney disease. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7 - 9 September, 2009. Carlton, Australia: Wiley InterScience. doi: 10.1111/j.1440-1797.2009.01176.x

Body mass index is independently associated with inflammatory burden in patients with chronic kidney disease

2008

Conference Publication

TWO CASES OF ADENOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS

Barraclough, K., Oliver, K., Playford, G., Preston, J., Campbell, S. and Isbel, N. (2008). TWO CASES OF ADENOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS. HOBOKEN: WILEY-BLACKWELL.

TWO CASES OF ADENOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS

2008

Journal Article

Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation

Nicol, David L., Preston, John M., Wall, Daryl R., Griffin, Anthony D., Campbell, Scott B., Isbel, Nicole M., Hawley, Carmel M. and Johnson, David W. (2008). Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation. BJU International, 102 (2), 188-193. doi: 10.1111/j.1464-410X.2008.07562.x

Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation

2008

Journal Article

Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease

Kaisar, M., Isbel, N. M. and Johnson, D. W. (2008). Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease. Reviews on Recent Clinical Trials, 3 (2), 79-88. doi: 10.2174/157488708784223853

Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease

2008

Journal Article

The impact of automated eGFR reporting and education on nephrology service referrals

Noble, E, Johnson, DW, Gray, N, Hollett, P, Hawley, CM, Campbell, SB, Mudge, DW and Isbel, NM (2008). The impact of automated eGFR reporting and education on nephrology service referrals. Nephrology, Dialysis, Transplantation, 23 (12), 3845-3850. doi: 10.1093/ndt/gfn385

The impact of automated eGFR reporting and education on nephrology service referrals

2008

Journal Article

The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin

Kaisar, Omar M., Johnson, David W., Prins, Judith B. and Isbel, Nicole (2008). The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin. Current Cardiology Reviews, 4 (4), 287-292. doi: 10.2174/157340308786349516

The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin

2008

Journal Article

Cutaneous manifestations of cytomegalovirus disease in renal transplant recipients: a case series

Kaisar, M. O., Kirwan, R. M., Strutton, G. M., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2008). Cutaneous manifestations of cytomegalovirus disease in renal transplant recipients: a case series. Transplant Infectious Disease, 10 (3), 209-213. doi: 10.1111/j.1399-3062.2007.00273.x

Cutaneous manifestations of cytomegalovirus disease in renal transplant recipients: a case series

2008

Journal Article

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease

Roger, Simon D., Suranyi, Michael G., Walker, Rowan G., Isbel, Nicole M. and COMFORT study group (2008). A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease. Current Medical Research and Opinion, 24 (8), 2181-2187. doi: 10.1185/03007990802240552

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease

2008

Journal Article

Change in live donor characteristics over the last 25 years: A single centre experience

Kaisar, Mohd O., Nicol, David L., Hawley, Carmel M., Mudge, David W., Johnson, David W., Preston, John M., Wall, Daryl R., Griffin, Anthony D., Campbell, Scott B. and Isbel, Nicole M. (2008). Change in live donor characteristics over the last 25 years: A single centre experience. Nephrology, 13 (7), 646-650. doi: 10.1111/j.1440-1797.2008.01039.x

Change in live donor characteristics over the last 25 years: A single centre experience

2007

Journal Article

Cardiovascular disease in patients with chronic kidney disease

Kaisar, M., Isbel, N. and Johnson, D. W. (2007). Cardiovascular disease in patients with chronic kidney disease. Minerva Urologica e Nefrologica, 59 (3), 281-297.

Cardiovascular disease in patients with chronic kidney disease

2007

Journal Article

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification

Johnson, David W., Armstrong, Kirsten, Campbell, Scott B., Mudge, David W., Hawley, Carmel M., Coombes, Jeff S., Prins, Johannes B. and Isbel, Nicole M. (2007). Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology, 12 (4), 391-398. doi: 10.1111/j.1440-1797.2007.00804.x

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification

2007

Journal Article

Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion

Wiggins, Kathryn J., Rumpsfeld, Markus, Hawley, Carmel M., O'Shea, Amanda, Isbel, Nicole M., Campbell, Scott B. and Johnson, David W. (2007). Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion. Nephrology, 12 (3), 218-223. doi: 10.1111/j.1440-1797.2006.00702.x

Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Journal Article

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

Johnson, David W., Craven, Ann-Maree and Isbel, Nicole Maree (2007). Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodialysis International, 11 (1), 1-14. doi: 10.1111/j.1542-4758.2007.00146.x

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients